Ophthalmic Business News

In this episode, Laura Enyedi, MD, and Cathleen McCabe, MD, and Dagny Zhu, MD, sit down and chat with guest Marguerite McDonald, MD, FACS, about her career as a woman in medicine and ophthalmology.

ViaLase completed enrollment in the VIA-002 pivotal trial investigating femtosecond laser image-guided high-precision trabeculotomy for the treatment of primary open-angle glaucoma, according to a press release.

The FDA approved Vabysmo for the treatment of macular edema following retinal vein occlusion, according to a press release from Genentech.

Well now, it seems as though I ruffled more than a few feathers with my annual anti-inflammatory review last month.

Bausch + Lomb introduced new surgical planning software for the Eyetelligence platform.

The FDA granted clearance to an investigational new drug application for EA-2351, a novel compound for the treatment of geographic atrophy, according to a press release from Endogena Therapeutics.

The European Medicines Agency granted priority medicine designation to ANX007 for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Annexon Biosciences.

Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs with intermediate optimized optics in the U.S., according to a press release.

The FDA approved Qlosi, a low-dose, preservative-free eye drop for the treatment of presbyopia in adults, according to a press release from Orasis Pharmaceuticals.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Peter Slack, Greg Kunst, Rich Small and Uday Devgan, MD, FACS, FRCS, live from OSN New York.